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ABSTRACT 
Background. Acidic-perfusion (AP) performed at the onset of reperfusion (i.e. acid-
postconditioning) is cardioprotective. We investigated the effect of AP on postischemic cardiac 
function and on the activity of endogenous superoxide-dismutase (SOD), catalase (CAT) and 
glutathione-peroxidase (GPX). The role of exogenous-CAT or -SOD on AP-cardioprotection 
was also investigated. Phosphorylation of redox-sensitive survival kinases (PKCε and ERK1/2) 
was also checked.   Materials and methods. Isolated rat hearts underwent 30-min ischemia and 
120-min reperfusion (I/R). Acidic-perfusion was obtained lowering [HCO3-] in the perfusion 
buffer. Infarct-size and left ventricular pressure were measured. Protocols: I/R only; I/R plus 
acidic-perfusion in early reperfusion (I/R+AP); I/R plus AP and CAT (I/R+AP+CAT) or SOD 
(I/R+AP+SOD). I/R+SOD and I/R+CAT additional hearts served as controls. AP and/or 
antioxidants were given in the initial 3-min of reperfusion. Enzyme activities were studied in 
postischemic phase (7th min of reperfusion) in I/R or I/R+AP, and in Sham (buffer-perfused) 
hearts.   Results. Acidic-perfusion with (I/R+AP+CAT or I/R+AP+SOD) or without (I/R+AP) 
antioxidant-enzymes resulted in a larger reduction of infarct size compared with I/R, I/R+SOD 
or I/R+CAT. Compared to I/R, the postischemic systolic and diastolic recovery of cardiac 
function were markedly improved by the addition of AP and by a lesser extent by AP+SOD or 
AP+CAT. Acidic-perfusion increased the postischemic activity of CAT and lowered those of 
SOD and GPX, compared to I/R only. Also the phosphorylation/activity of ERK1/2 and PKCε 
were increased by AP.   Conclusions. Acid-postconditioning affects the activity of endogenous-
antioxidant-enzymes, activates ERK1/2-PKCε pathways and protects against myocardial I/R 
injury. The combination of AP and exogenous-SOD or -CAT still provides cardioprotection. It is 
likely that intracellular (not-extracellular) redox condition plays a pivotal role in acidic 
protection. 
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INTRODUCTION 
It is well known that ischemia and reperfusion (I/R) in the heart induce extensive tissue 
damage and that a substantial part of myocardial cell death initiated by ischemia occurs at the 
time of reperfusion [1-13]. I/R injury can be thus prevented by interventions applied at the time 
of reflow, that is postconditioning (PostC), which is obtained with brief intermittent ischemia or 
with pharmacological agents at beginning of reperfusion [4,5,8,12]. As such, ischemic and 
pharmacological PostC clinical application has been rapid for both STEMI (ST-elevation) 
patients undergoing coronary reperfusion and for patients undergoing on pump cardiac surgery 
[3-5]. 
Ischemia will cause tissue acidification which initially protects against tissue damage, but 
prolonged acidosis associated with limited nutrient level will eventually cease ATP generation 
[1-5,8,9,13-5]. Nevertheless, a few minutes acidic perfusion (AP) immediately after release of a 
prolonged coronary occlusion mimics infarct reduction seen with PostC [1-4,15]. In fact, 
delayed normalization of intracellular pH (pHi) during reperfusion together oxygen delivery 
plays an important role in the cardioprotective effects of PostC [1,2,4].  
The generation of reactive oxygen species (ROS) is believed to be among the major causes of 
I/R injury. However, recent studies have demonstrated that ROS can also contribute to PostC 
cardioprotection activating survival kinases, including protein kinase C (PKC) and extracellular-
signal-regulated kinases (ERK1/2) [1,2,11,16]. Importantly, either PostC protection or AP 
protection can be abolished by cell permeant ROS scavengers (N-acetyl-L-cysteine or N-2-
mercaptopropionyl glycine) given in early reperfusion [1,2,11,16]. This suggests that pHi may 
play a pivotal role in regulating intracellular redox equilibrium in a moment in which oxygen is 
re-introduced. 
Many different endogenous enzymes regulate the intracellular homeostasis of ROS. For 
instance, in the myocardium, the main antioxidant-enzymes include: superoxide dismutases 
(SODs) which convert superoxide (O2-) to hydrogen peroxide (H2O2), as well as catalase (CAT) 
) and glutathione peroxidase (GPX) which regulate steady-state levels of H2O2 by conversion to 
water [5,8]. 
We recently have shown that PostC down-regulates SOD and up-regulates CAT activity [10]. 
This is in line with the observation that PostC affect the equilibrium of redox conditions in 
reperfusion [1,2,4,5,8,11,16]. 
Since all enzymatic activities are strongly influenced by pHi, we hypothesize that an acid 
buffer perfusion in the early reperfusion phase may affect the activity of anti-oxidant enzymes. 
To verify this hypothesis we studied the cardioprotective effects of a few minutes of AP in early 
reperfusion and the influence on endogenous SOD, CAT and GPX levels and activities in an 
isolated heart model. We also tested if exogenous SOD or CAT, which are non-cell permeant 
antioxidants, co-infused with acidic buffer may affect cardioprotection induced by acid buffer 
reperfusion. Finally, we checked whether AP may favor the activation/phosphorylation of two 
redox-sensitive survival kinases, namely ERK1/2 and PKCε. 
 
 
MATERIALS AND METHODS.  
Animals 
Male Wistar rats (5-6 month old, body weight 450–550 g) derived from Janvier, Le Genest St 
Isle - France, received humane care in compliance with Italian law (DL-116, Jan. 27, 1992) and 
in accordance with the Guide for the Care and Use of Laboratory Animals published by the US 
National Institutes of Health (NIH Publication No. 85-23, revised 1996). 
Isolated heart perfusion 
The methods were similar to those previously described [6,7,10,11]. In brief, after anesthesia 
chest was opened and heart excised. Hearts were constant-flow perfused (9 ml/min/g) with 
Krebs–Henseleit buffer solution (127 mM NaCl, 17.7 mM NaHCO3, 5.1 mM KCl, 1.5 mM 
CaCl2, 1.26 mM MgCl2, 11 mM D-glucose (Sigma-Aldrich Corp., St. Louis, MO, USA), and 
gassed with 95% O2 and 5% CO2). The hearts were instrumented to record coronary pressure 
and left ventricular pressure (LVP), electrically paced at 280 b.p.m. and kept in a temperature-
controlled chamber (37°C). 
Experimental protocols  
Each heart was stabilized for 30 min and subjected to a specific protocol, which included in all 
groups a 30 min of global, normothermic ischemia, followed by 120 min of reperfusion in all 
groups. Pacing was discontinued on initiation of ischemia and restarted after the third minute of 
reperfusion in all groups [6,7,10,11].  
After stabilization Control group hearts (I/R, Group 1, n=6) were exposed to 30 min ischemia 
and then to 120 min reperfusion only. In Group 2 (Acidic Perfusion, AP; n=6) acidic solution 
was given at the beginning of reperfusion for 3 min. Acidic (pH 6.6) solution was prepared by 
lowering [NaHCO3] to 4.0mM while maintaining the same gas mixture containing 5% CO2. 
[Na+] was kept constant (144±1 mM) in all solutions by modifying [NaCl] as necessary [3]. In 
Group 3 (I/R+AP+CAT, n=6) and Group 4 (I/R+AP+SOD, n=6) hearts underwent I/R in the 
presence of CAT (100 U/ml) or SOD (10 U/ml), respectively. Antioxidants, either CAT or SOD 
(Sigma-Aldrich, USA), were given at the beginning of reperfusion for 3 min in the presence of 
the acidic buffer at doses previously used in isolated rat hearts [10,17]. In order to test the effects 
of antioxidants given alone for 3 min in early reperfusion, in additional hearts (n=6) I/R protocol 
was followed by 3 min infusion of CAT (100 U/ml; I/R+CAT) or SOD (10 U/ml; I/R+SOD), at 
the beginning of 120 min reperfusion. 
Assessment of cardiac function  
A polyvinyl-chloride balloon was placed into the left ventricle (LV), filled with saline and 
connected to the electromanometer to obtain an end diastolic LVP (LVEDP) of 5 mmHg. Such a 
volume of LV was maintained throughout the experiment [6,7,10,11]. 
Coronary perfusion pressure, coronary flow and LVP were monitored to assess the preparation 
conditions. LVP was analyzed offline with LabView software (National Instruments).  
Assessment of myocardial injury 
Infarct areas were assessed at the end of the experiment as previously described [6,7,10,11]. In 
brief, immediately after reperfusion hearts were rapidly removed from the perfusion apparatus 
and the LV dissected into 2–3 mm circumferential slices. Following 20 min of incubation at 
37°C in 0.1% solution of nitro-blue tetrazolium in phosphate buffer, unstained necrotic tissue 
was carefully separated from stained viable tissue by an independent observer, who was unaware 
of the protocols. The necrotic mass was expressed as a percentage of total left ventricular mass 
which was considered as risk area. 
Antioxidant Enzyme Activities and Western Blotting 
Hearts (n= 4 for each group) were subjected to 180 min perfusion only (i.e. Sham), or to I/R 
only or to I/R plus AP, as above described for Groups 1 and 2.  
Samples of these hearts were homogenized on ice in RIPA Lysis buffer and processed as 
previously described for protein quantification with Western blotting [9,10]. 
In samples of these hearts the activity of CAT, SOD and GPX was tested at 7th min of 
reperfusion. Sham hearts were tested at corresponding time points (baseline and after 37 min 
perfusion only) and after 150 min of buffer perfusion only, in order to have reference points and 
to verify stability of enzyme activities. The activity of enzymes was analyzed according to the 
manufacturer's directions using Cayman chemical kits (Ann Arbor, MI, USA) for CAT and SOD 
and with OXItech chemical kit (Zeptometrix Co., Buffalo, NY;USA) for GPX. Tissues from 
heart of rats were homogenized, cell debris was pelleted and the resulting supernatants were 
used for the enzyme activity assays. CAT, SOD and GPX activities were measured 
spectrophotometrically at 540, 450 and 340 nm wavelength, respectively. A unit of CAT activity 
was defined as the amount of enzyme that caused the formation of 1.0 nmol of formaldehyde per 
minute at 25°C. A unit of GPX was defined as the amount of enzyme that will cause the 
formation of 1 µmol NADP+ from NADPH per min at pH 8.0 and at 25ºC. A unit of SOD 
activity was defined as the amount of SOD needed to exhibit 50% dismutation of the produced 
superoxide radical at 25°C. The final enzymes activities were calculated by normalizing the 
results to the total protein concentration of the whole extract. 
Western blotting  
About 50 µg of protein extracts were separated by SDS-PAGE on 8% (PKCε and phospho-
PKCε), 10% (SOD, CAT and β-actin) or 12% (for ERK1/2 and phospho-ERK1/2) gel and 
transferred to PVDF membrane (GE-Healthcare). The membranes were incubated overnight with 
the following primary antibodies: anti ERK1/2, anti–phospho-(Thr-202/Tyr-204)-ERK1/2; anti-
PKCε, anti-phospho-(Ser-729)-PKCε, anti SOD and anti-CAT, (St. Cruz, and BD Biosciences), 
all were diluted according to the manufacturer's instructions. Immunoblotted proteins were 
visualized by using Immuno-Star HRP Substrate Kit (BioRad) and quantified by Kodak Image 
Station 440CF. To confirm equal protein loading, blots were stripped with 0.4 M NaOH and then 
re-blotted with an anti-actin antibody (Sigma). Image analyses were performed by the Kodak 1D 
3.5 software [9,10]. Western blot densiometric data are normalized with respect to the mean value 
of single value loading of β-actin, and data have been presented as the normalized ratio of 
phospho to total kinases.  
Statistical analysis 
All data are expressed as means±SEM. One-way ANOVA and Newman–Keuls multiple 
comparison test (for post-ANOVA comparisons) have been used to compare infarct size. 
Functional data (Figs 2- 3) were compared with the analysis of area under the curve during 
reperfusion. A t test with Bonferroni correction was also used to compare the last-time points of 
functional data (Figs 2-3). Postischemic enzymatic activity was related to the mean value of the 





Total infarct size (Fig 1), expressed as a percentage of risk area, was 61±5% in Control Group 
1. The early reperfusion with acidic buffer (I/R+AP) significantly reduced the infarct size to 
25±5% (p<0.05 vs I/R Control Group). 
The infusion of SOD and CAT during the early reperfusion with Acidic buffer (I/R+AP+CAT 
Group 3, I/R+AP+SOD Group 4) did not abolish the cardioprotection by Acid buffer (infarct 
size 28±7%, and 27±4%; p<0.05 vs. I/R Control Groups, p=NS vs I/R+AP for both). 
The treatment with antioxidant-enzymes only (I/R+SOD or I/R+CAT) during the first 3-min of 
reperfusion did not significantly change infarct size (71±7% and 76±7%, respectively) with 
respect to the I/R Control Group. The infarct size in these two groups resulted significantly 
higher (p< 0.05 for all) than I/R+AP, I/R+AP+SOD and I/R+AP+CAT groups. 
Cardiac functional parameters 
Baseline values of dLVP, dP/dtmax, LVEDP and dP/dtmin were similar among groups (data not 
shown). 
Systolic function 
In Fig 2, dLVP and dP/dtmax (panels A and B, respectively) are reported as percent variation 
with respect to baseline level. The hearts of the I/R Control Group displayed a marked limitation 
of dLVP recovery; in fact at the end of reperfusion dLVP was about 35% of baseline level 
(p<0.05 vs baseline). In I/R+AP a significant improvement of the dLVP recovery was observed 
during reperfusion period (p<0.05 vs I/R group); in particular, at the end of reperfusion the 
recovery was about 110% (p< 0.05 vs I/R) of baseline levels. Yet, in I/R+AP+CAT or 
I/R+AP+SOD, the dLVP recovery was significantly (p<0.05 vs Control group) improved. 
Nevertheless, the recovery of dLVP in these two groups was significantly lower that that of 
I/R+AP. A similar trend was observed for dP/dtmax recovery. Of note, in the additional hearts in 
which CAT or SOD was used alone the recovery of dLVP and dP/dtmax was similar to that of I/R 
Control Group (data not shown). 
Diastolic function 
Diastolic function is represented by the level of LVEDP and by dP/dtmin percent recovery 
during reperfusion (Fig. 3 panels A and B). In I/R Control Group, it was observed a marked 
increase of LVEDP, an index of hypercontracture. In I/R+AP group a striking limitation of 
contracture development was observed during reperfusion (Fig. 3 panel A), though LVEDP 
remains higher than baseline level (i.e. in the contracture range). Yet, in I/R+AP+CAT and in 
I/R+AP+SOD groups contracture development was somewhat intermediate between I/R and 
I/R+AP groups. Similarly dP/dtmin recovery was improved by acidic perfusion, even in the 
presence of non-cell permeant exogenous SOD or CAT. In the additional hearts in which CAT 
or SOD was used alone the recovery of LVEDP and by dP/dtmin was similar to that of I/R 
Control Group (data not shown). 
Antioxidant enzyme activities 
Basal activity of SOD CAT, and GPX detected after 30-min stabilization was 1.49±0.5 U/ml, 
1.03±0.3 U/ml and 1.98±0.3 U/ml, respectively. No appreciable changes with respect to these 
baseline activities were observed on samples of Sham hearts collected after stabilization and 
further 37 or 120 min of perfusion (data not shown). These two latter time points in Sham hearts 
correspond to the 7th and 120th min of reperfusion in I/R and I/R+AP hearts, and were collected 
in order to verify the stability of activities during the period of observation in the absence of 
experimental interventions. 
In hearts subjected to I/R (I/R or I/R+AP) the analysis of enzyme activity was measured at the 
7th of reperfusion because after triggering of protection at this time point there are relevant 
modifications of protective signaling pathways [10,18]. In Fig 4, data are represented as percent 
variation with respect to the mean value of baseline level. As can be seen, in the I/R samples at 
the 7th minute of reperfusion SOD activity increased to 140±15% (p< 0.05 vs baseline and 
Sham). Yet, the activities of CAT and GPX were not changed by I/R. In the I/R+AP samples, the 
activity of SOD resulted lower than that of I/R, but similar to that of Sham; CAT activity 
resulted higher than those of Sham and I/R; yet GPX activity resulted lower than those of Sham 
and I/R. 
Western blotting analysis showed that levels of antioxidant-enzymes were stable after 7 min 
reperfusion in all the experimental condition tested (data not shown). 
Phosphorylation levels of Por-Survival Kinases (Fig 5) were differently affected by the 
different protocols. In particular, the AP treatment induced a significant increase of 
phosphorylation/activation of PKCε and ERK1/2 with respect to I/R protocol. 
 DISCUSSION 
Clearly the effectiveness of ischemic postconditioning protocols in limiting infarct size 
depends on their ability to delay normalization of intracellular acidosis during the first minutes 
of reperfusion [1,4,5,8]. 
Here we show that acidic perfusion limits myocardial injury at least in part through 
modification of the activity of endogenous antioxidant-enzymes at the onset of reperfusion. We 
also show that the acidic early reperfusion not only reduces infarct size but also improves 
postischemic cardiac function. It seems that acidic perfusion prevents the stunning and limits 
hypercontracture. These beneficial effects of acidosis in early reperfusion have been correlated 
to the prevention of calpain activation and to PKG activation [3,4,6]. Here we show that PKCε 
and ERK1/2 are activated by AP in early reperfusion. Actually, both PKC and PKG activation 
are followed by phospholamban phosphorylation [19, and unpublished observations of the 
authors], which may explain, at least in part, diastolic and systolic cardiac function 
improvement. Most notably, it has been suggested that limitation of infarct size and limitation of 
contracture are more robust indicators of protection than systolic functional recovery [20]. 
The exogenous co-infusion for three minutes of CAT or SOD does not avoid beneficial effects 
of acidic reperfusion against infarct size, but only slightly blunts the improvement of cardiac 
function induced by early acidic reperfusion. It is likely that exogenous-enzymes (CAT and 
SOD) do not penetrate the cardiomyocytes and only slightly interferes with cardiac mechanical 
function. This interference might occur affecting the second-messenger signaling of ROS; 
specifically H2O2, which is cell permeable, has longer half-life, can diffuse across longer 
distances and can regulate cardiac function [5,8]. 
The protective effect of acidosis during the first minutes of reperfusion has been demonstrated 
in different models, including isolated cardiomyocytes and intact hearts [e.g. 1-3,10,13]. This 
protective effects is the consequence of the combined action of different systems, including 
Na+/H+ exchanger (NHE), Na+/HCO3-2 synport and H+-coupled lactate efflux [1-5,21], as well as 
slowed ATP hydrolysis and closure of closed the gap-junctions, which may prevent propagation 
of necrosis [4,22,23]. In particular, it seems that cell death or survival depends on the correlation 
between the time of pHi recovery and of Ca2+ overload reduction: if the former occurs first, 
lethal reperfusion injury may occur, if it is the latter which occurs first, reperfusion injury is 
attenuated [4,22,23]. Also PostC maneuvers (brief occlusions and reperfusions after ischemia) 
are effective because they delay the recovery of postischemic pHi, which inhibits mitochondrial 
permeability transition pores (mPTP) and proteolitic enzymes calpain [1-5,8]. Moreover, early 
acidosis and ROS signaling keeping closed mPTP give to the heart enough time to activate 
protective signaling pathways [1,2,5,8,11,18], including ROS-dependent activation of pro-
survival kinase, such as PKCε and ERK1/2. In fact, it is well known that PKCε and ERK1/2 are 
activated by ROS signaling, with a relevant role of inactivation of phosphatases [1,2,4,5,8]. 
Importantly, the ROS signaling, which we demonstrated to be of pivotal importance in PostC 
[11] has been documented to be mandatory also in acidic perfusion in early reperfusion [1,2]. 
This suggests that the slow recovery of postischemic pHi modifies the balance between ROS 
production and ROS scavenging in early reperfusion in a favorable cardioprotective balance. Of 
note, acidosis is also responsible of non-enzymatic nitric oxide formation [24], which has been 
suggested to be involved in PostC-triggering [6,10]. Here we demonstrate that the 
cardioprotection induced by acidosis modulates the activity of anti-oxidant enzymes (see Fig 4). 
How these effects on antioxidant-enzymes modify the ROS balance in favor of a species or 
another can not be inferred from our experiments. However, the lowering of SOD activity with 
respect to I/R, in one hand suggest a lower level of dismutation, whereas the different effects on 
CAT and GPX activities (increase and decrease, respectively) in the other hand suggest a 
compartmentalization of conversion to water and oxygen of H2O2. Of note, hydrogen peroxide 
may exert a protective signaling role, but may be also a potent oxidizing agent that can be 
converted to hydroxyl radical in the presence of ferric compounds [5]. Thus a 
compartmentalization of its conversion might be beneficial limiting its indirect strong oxidizing 
capacity. Actually, the nature, the site and the moment of production of protective ROS are 
matter of intense debate [e.g. 1,2,5,6,8,10,24]. Nevertheless, as said ROS may activate pro-
survival kinases [1,2,4,5,8]. Here, we show that AP activates pro-survival kinases, likely via the 
modulation of redox-environment [1,2, and present study].  
Importantly, the optimal pH for SOD, GPX and CAT activity is reported to be around 7.8, 7.4 
and 7.0, respectively [25]; see also Sigma-Aldrich Product Information and references therein 
(www.sigma-aldrich.com). The optimal pH may explain why only CAT increases its activity 
when acidosis (pH lower than 7.4) persists in early reperfusion [1,2,4]. 
In conclusion, here we confirm that acidic early reperfusion protects against myocardial I/R 
injury and affects the activity of endogenous antioxidant-enzymes, thus influencing intracellular 
redox conditions as well as ERK1/2 and PKCε upregulation, in early reperfusion. Contrary to 
cell permeant ROS scavengers [1,2], exogenous CAT or SOD are not able to counteract the 
protective effects of early acidic reperfusion. 
Clinical considerations 
A few studies have analyzed the effect of transient acidosis during reperfusion in large 
mammalians (dogs [26,27] and pigs [13]) confirming a protective action against infarction. 
However, some concerns derive from the possibility to increase arrhythmias [13]; although this 
observation might be species-specific and at variance with the strong anti-arrhythmic effect of 
PostC (i.e. intermittent ischemia/reperfusion). In fact, acidic reperfusion reduces the incidence of 
ventricular fibrillation in rat heart models of regional ischemia [28,29], and there are early 
reports which propose intermittent ischaemia/reperfusion as a maneuver against ventricular 
arrhythmias in reperfusion in different species [30-32], including pigs [33] and humans [34]. 
Nevertheless, NHE inhibitors (eniporide or cariporide) were used as an adjunct to therapy in 
patients in order to delay pHi recovery during reperfusion in ESCAMI, GUARDIAN and 
EXPEDITION trials and gave largely disappointing results [36-37]. Further research is needed 
to investigate the relationship between acidosis, ROS signaling and other mechanisms of PostC 
cardioprotection and to identify potential ways to translate this knowledge to the treatment of 
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FIGURE LEGENDS 
Fig. 1. Infarct size following 30 min of global ischemia and 30 min reperfusion. Infarct size is 
expressed as the percent of left ventricle, which is considered the risk area. I/R = 30 min 
ischemia and 120 min reperfusion; AP = acid perfusion given for 3 min in early reperfusion; 
CAT= catalase, SOD= superoxide dismutase given for 3 min in early reperfusion. 
*p < 0.05 vs. I/R group, #p < 0.05 vs. groups treated with AP with and without antioxidant 
enzymes (CAT or SOD). n=6 for each group. 
 
Fig. 2. Heart contractile function during 120 min reperfusion following 30 min global ischemia 
(vertical dashed lines). (A) Percent temporal change in developed left ventricular pressure 
(dLVP) and (B) in maximum rate of increase in LVP during systole (dP/dtmax). I/R = 30 min 
ischemia and 120 min reperfusion; AP = acid perfusion given for 3 min in early reperfusion; 
CAT= catalase, SOD= superoxide dismutase given for 3 min in early reperfusion.  
*p < 0.05 vs. I/R group, #p < 0.05 vs. groups treated with acid perfusion (AP) plus antioxidant 
enzymes (CAT or SOD). n=6 for each group. 
 
Fig. 3.  Heart diastolic function during 120 min reperfusion following 30 min global ischemia 
(vertical dashed lines). (A) Temporal change in left ventricular end diastolic pressure (LVEDP) 
and (B) percent change in maximum rate of decrease in LVP during diastole (dP/dtmin). I/R = 30 
min ischemia and 120 min reperfusion; AP = acid perfusion given for 3 min in early reperfusion; 
CAT= catalase, SOD= superoxide dismutase given for 3 min in early reperfusion. *p < 0.05 vs. 
I/R group, #p < 0.05 vs. groups treated with acid perfusion (AP) plus antioxidant enzymes (CAT 
or SOD). n=6 for each group. 
 
Fig. 4. Antioxidant enzyme activity in Sham, ischemia/reperfusion (I/R), and acid buffer 
perfusion (I/R+AP). Panels from top to bottom are superoxide dismutases (SOD), catalase 
(CAT) and glutathione peroxidase (GPX) activities at the 7th min of reperfusion. Data are 
presented as percent variation of baseline level. *p < 0.05 vs. Sham group, #p < 0.05 vs. I/R 
group. n=4 for each group. 
 
Fig. 5. Western blot analysis for two Pro-Survival Kinases (PKCε and  ERK1/2) at the 7th min 
of reperfusion. Representative Western blots and relative densitometry showing that AP given in 
early reperfusion results in an increased phosphorylation of PKCε and  ERK1/2, with respect to 
I/R group. Total kinases and phospho-kinases for each heart are normalized to β-actin, and data 
are presented as the normalized ratio of phospho to total kinases. Values are mean ± SEM. 
*p<0.05 with respect to I/R; #p<0.05 with respect to Sham. n=4 for each group. 
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